Core Laboratories (CLB) Other Accumulated Expenses (2022 - 2026)

Core Laboratories has reported Other Accumulated Expenses for 5 years, with the latest figure at $17.4 million in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses rose 279.32% year-over-year to $17.4 million; the trailing twelve-month figure through Mar 2026 stood at $17.4 million (up 279.32% YoY), and the FY2025 full-year result was $4.3 million, down 47.63% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $17.4 million, up from $4.3 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $17.4 million in Q1 2026, with the low at $3.2 million in Q3 2023.
• Historically, Other Accumulated Expenses has averaged $6.6 million across 5 years, with a median of $4.8 million in 2022.
• Annual changes were most pronounced in 2025 — Other Accumulated Expenses sank 57.82% — and 2026, when it jumped 279.32%.
• Core Laboratories' Other Accumulated Expenses stood at $4.8 million in 2022, then jumped by 58.67% to $7.7 million in 2023, then advanced by 6.61% to $8.2 million in 2024, then slumped by 47.63% to $4.3 million in 2025, then soared by 306.67% to $17.4 million in 2026.
• The last three Other Accumulated Expenses figures came in at $17.4 million (Q1 2026), $4.3 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.